Liquid dosage forms with antibacterial activity

Authors

  • O. I. Mykhalyk

DOI:

https://doi.org/10.14739/2409-2932.2015.1.41704

Keywords:

Anti-Infective Agents, Fluorenes, Local Dosage Forms

Abstract

The development and implementation of effective liquid medicines with antiseptic action on the basis of new substances and their complex combinations into medical practice is an important task of modern pharmaceutical and medical science. In the "National List of Essential medicines and medical devices" on anatomical, therapeutic and chemical classification the code D10AE was assigned to antiseptic preparations.The Purpose was to study modern liquid medications with antiseptic action in regulatory documents of Ministry of Health of Ukraine, State Formulary of drugs.Antiseptic and disinfectants are separated by the chemical structure into inorganic compounds (halogens and halogencontaining substances, oxidants, acids, alkalis, compounds of heavy metals) and organic compounds (aliphatic: aldehydes, alcohols), detergents (surface-active substances), aromatic: phenol derivatives (as birch tar containing phenol, toluene, xylene, tar, etc.), nitrofuran and hydroxyquinoline compounds, dyes, antibiotics for topical use (microcide, novoimaninum, gramicidin).Boric acid, ethanol, hydrogen peroxide, brilliant green and the most efficient – iodine preparations appeared under antiseptic preparations in Compendium up to 2000.Iodine preparations containing elemental iodine are particularly distinguished among the halogens. In modern medical practice, pharmaceutical compositions of iodine molecules in polymeric compounds (Iodinolum, Iodopiron, Iodovidon, Рovidone – iodine) are among the most important ones. Introduction of iodine into  molecules of polymeric compounds makes it possible to preserve a wide range of antimicrobial, fungicidal, antiviral activity, neutralize toxicity when injected into the body of higher animals and humans.In the pharmaceutical and medical practice Dimexidum (DMSO) has been used for a long period as a solvent and medication. Modern effective drug with antimicrobial and antiviral action containing Іodine, Glycerin and Dimexidium called Ioddicerinum is used in clinical practice .In the State Formulary of drugs large group of medicines is represented by 5-nitrofuran derivatives (Furacilin, Furazolidone, Furaplast, Lifusolum). Currently  the most effective antiseptics include surfactants (Chlorhexidine). The newest agents with wide range of indications comprise Miramistinum, Decametoxine. A well-known Ethakridine lactate (syn. Rivanolum) belongs to acridine group and it is used in a variety of dosage forms. Dioxidin as a quinoxaline derivative is an  active ingredient of the drug Dioxisolum.In Ukraine since 2000, a new class of drugs, namely derivatives of fluorene, was introduced into medical practice. Its derivatives are well-known antivirals Florenal and Amixin .Search for highly efficient broad-spectrum agents among fluorenes led to the creation of Flurenizide, which is the Preparation with antimicrobial, antichlamydial, immunomodulting, antioxidant, hepatoprotective, antiinflammatory and antiviral actions. Indicators of antiviral activity of Flurenizide exceed those of Amixin.Based on Flurenizide new liquid medicines have been developed to treat skin infections. Among them are Flumexide (2 % suspension of Flurenizide in 30% aqueous solution of Dimexidum), antiseptic solution of 1% Flupetsal, liquid antydemodex agent Flulotion.Development of  various pharmaceutical compositions used on Flurenizide is important in treatment of skin infections.

References

Krasil'nikov, A. P. (1995). Spravochnik po antiseptike [Handbook of antiseptic]. Minsk: Vysshaya shkola. [in Belarus].

Kovalenko, V. N., & Vyktorova, A. P. (Eds.) (2000) Kompendium: Lekarstvennye preparaty [Compendium: Pharmaceuticals Preparations]. Kyiv: Morion [in Ukrainian].

(1996) Zakon Ukrayiny «Pro likarski zasoby» [The Law of Ukraine «On Medicines»]. Vidomosti Verkhovnoi Rady, 22, 86. [in Ukrainian].

(2001) Derzhavna farmakopeya Ukrayiny [The State Pharmacopoeia of Ukraine]. Kharkiv [in Ukrainian].

Postanova Kabinetu Ministriv Ukrayiny Pro zatverdzhennia Natsionalnoho pereliku osnovnykh likarskykh zasobiv i vyrobiv medychnoho pryznachennia: pryiniata 29 bereznia 2006 roku №400 [Resolution of the Cabinet of Ministers of Ukraine from March 29 2006 №400. Kyiv [in Ukrainian].

Palii, H. K. (2004) Antyseptyky v profilaktytsi i likuvanni infektsiy [Antiseptics in the prevention and treatment of infections]. Kyiv: Zdorovia [in Ukrainian].

Mashkovskij, M. D. (2012) Lekarstvennye sredstva [The medicaments]. (Vol. 2). Moscow: Novaia volna. [in Russian].

Kovalchuk, V. P. (2006) Kharakterystyka arsenalu antyseptychnykh zasobiv, zareyestrovanykh v Ukrayini [Characteristics arsenal of antiseptic products registered in Ukraine]. Biomedical and biosocial anthropology, 6, 71–76 [in Ukrainian].

Moroz, V. M., Palii, H. K., & Volianskyi, Yu. L. (2000) Dosyahnennya ta stratehiya doslidzhennya novykh vitchyznyanykh likars'kykh antyseptychnykh preparativ [Achievements and strategy research of new home medical antiseptic drugs]. Visnyk Vinnytskoho derzhavnoho medychnoho universytetu, 2, 260–264 [in Ukrainian].

Nakaz Ministerstva okhorony zdorovia Ukrainy Instruktsiia do medychnoho zastosuvannia preparatu Dekasan vid 10 lystopada 2006 roku №743 [Іnstructіons for medical use of the drug Dekasan (Dekasanum) from Novembe 10 2006 №743]. Retriеved from http://uf.ua/products/ Dekasan [in Ukrainian].

Nakaz Ministerstva okhorony zdorovia Ukrainy Instruktsiia do medychnoho zastosuvannia preparatu Miramistin vid 3 lystopada 2008 roku №620 [Іnstructіons for medical use of the drug Miramistin (Miramistinum) from Novembe 3 2008 №620. Retriеved from http://health.mail.ru/drug/ Miramistin [in Ukrainian].

Nakaz Ministerstva okhorony zdorovia Ukrainy Instruktsiia do medychnoho zastosuvannia preparatu Dymetylsul'foksyd vid 23 travnia 2006 roku №309 [Іnstructіons for medical use of the drug Dimethyl sulfoxide from May 23 2006 №309. Retriеved from https://ru.wikipedia.org/wiki/ Dimethyl sulfoxide [in Ukrainian].

Rybachuk, V. D., Rybachuk, D. V., & Yehorov, I. A. (2005) Aktualnist rozrobky novykh preparativ dlia likuvannia alerhichnykh dermatoziv [The urgency of developing new drugs for the treatment of allergic dermatoses]. Dosiahnennia ta perspektyvy rozvytku farmatsevtychnoi haluzi Ukrainy. Proceedings of the 6th National Congress of Pharmacists Ukraine. Kharkiv. [in Ukrainian].

Mykhalyk, O. I. (2013). Suchasni likarski zasoby dlia khimioterapii virusnykh infektsii [Modern medicines for viral infections hemioterapiyi]. Lviv [in Ukrainian].

Petrukh, L. I. (2003). Aktualnist stvorennia i vprovadzhennia u promyslove vyrobnytstvo novykh likarskykh zasobiv. Zbirnyk opysiv vynakhodiv [The relevance of the creation and implementation to production of new drugs. Collection descriptions of inventions]. Lviv: LTsNTEI [in Ukrainian].

Petrukh, L. I., Mykhalyk, O. I., Pronyuk, O. V., & Mykhaylyuk, N. I. (2002) Biolohichna dostupnist flurenizydu [Вioavailability Flurenizydе]. Abstracts of Papers of the 9th Congress of the World Federation of Ukrainian Medical Associations (WFUMA), (pp. 467–468). Luhansk [in Ukrainian].

Petrukh, L. I. (2008) Fluoreny yak tuberkulostatyky. Flurenizyd: mikrobiolohichni, farmakolohichni ta klinichni aspekty [Fluorene as tuberkulostatyky. Flurenizyd: mikrobioloґichni , farmakoloґichni and clinical aspects]. Lviv [in Ukrainian].

Danilenko, M. V., & Turkevich, N. M. (1976). Klinicheskoe primenenie Dimeksida [Clinical application Dimexidum]. Kyiv: Zdorov`ya [in Ukrainian].

Petrukh, L. I., Mykhalyk, O. I., Pavlii, R. B., & Avdosieva, I. K (patentee) Pat. 81084. Zastosuvannya N-(9-fluoreniliden)-N'-izonikotynohidrazydu (Flurenizydu) yak antyvirusnoho zasobu shchodo RNK-genomnykh virusiv. [The use of N- ( 9- fluoreniliden ) -N'- izonikotyno-hidrazydu (Flurenizydu) as antiviral agents with respect to RNA viruses ґenomnyh]; opubl. 25.06.2008. Biul., 12. [in Ukrainian].

Petrukh, L. I., Mryhlotskyi, M. M., Bilynskyi, B. T. & Kravets, A. I. (2002) Klinichni aspekty vyvchennia flumeksydu. [The clinical aspects of the study flumeksydu]. Farmatsiia XXI stolittia. Proceedings of the All-Ukrainain Scientific and Practical Conference, (pp. 177–178 ). Kharkiv [in Ukrainian].

Buianova, O. V., Petrukh, L. I., & Hryniuk, S. M. (patentee) Pat. 62220. Sposib likuvannya psoriazu [A method of treating psoriasis]; – opubl. 31.01.2003. Byul., 12. [in Ukrainian].

Yakubovych, H. M. (1999). Flurenizyd yak novyi imunomoduliator v likuvanni khvorykh na aktyvni formy syfilisu. [Flurenizyd as a new immunomodulator in the treatment of patients with active syphilis]. Dermatovenerolohiia, kosmetolohiia, seksopatolohiia, 2, 120–122 [in Ukrainian].

Kitsera, O. (1996). Klinichna otorynolarynholohiia [Clinical Otorhinolaryngology]. Lviv [in Ukrainian].

Zhuraiev, R. K., Abrahamovych, O. O., Petrukh, L. I., Vynnyk-Zhuraieva, I. O., & Mykhalyk, O. I. (patentee) Pat. 67138. Sposib likuvannya khvorykh na reaktyvnyy khlamidiye-asotsiyovanyy artryt [Method for the treatment of patients withreactive arthritis hlamidiyeasotsiyovanyy]. opubl. 15.06.2004. Biul., 6 .[in Ukrainian].

Petrukh, L. I., & Mykhalyk, O. I. (patentee) Pat. 275600. Antyseptychnyy zasib [Antiseptic]. opubl. 15.05.2006. Biul., 5 [in Ukrainian].

Petrukh, L. I., Ostrovska, L. L., Mykhalyk, O. I., & Ostrovskyi, Ya. Z. (patentee) Pat. 82787. Zastosuvannya farmatsevtychnoyi kompozytsiyi dlya likuvannya khronichnoho otodektozu [The use of a pharmaceutical composition for the treatment of chronic otodektozu]. opubl. 12.05.2008. Biul., 9. [in Ukrainian].

Abrahamovych, L. Ye. (patentee) Pat. 24863. Protydemodytsydnyy, protymikrobnyy, protyvirusnyy, antyoksydantnyy ta imunomodulyuval'nyy zasib «flulos'yon» [Protidemoditsidny, protimіkrobny, protivіrusny, antioxidant that іmunomodulyuvalny zasіb «flulosyon»]. opubl. 10.07.2007. Biul., 10 [in Ukrainian].

How to Cite

1.
Mykhalyk OI. Liquid dosage forms with antibacterial activity. Current issues in pharmacy and medicine: science and practice [Internet]. 2015Mar.3 [cited 2024Apr.26];(1). Available from: http://pharmed.zsmu.edu.ua/article/view/41704

Issue

Section

Review